Zijing Lin
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
The current status and hot topics of endoscopic techniques in breast cancer surgery: a global bibliometric and visualization analysis (1999-2024).
Journal: Gland surgery
Published: October 02, 2025
Magneto-photo-acoustic Nanotheranostics Orchestrate Ferroptosis-Immune Cross Talk for Spatiotemporally Amplified Triple-Negative Breast Cancer Therapy.
Journal: Biomaterials research
Published: April 29, 2025
The role of gut microbiota in Tirzepatide-mediated alleviation of high-fat diet-induced obesity.
Journal: European journal of pharmacology
Published: March 07, 2025
Characteristics and prognosis of Her2-negative breast cancer expressing unbalanced hormone receptor.
Characteristics and prognosis of Her2-negative breast cancer expressing unbalanced hormone receptor.
Journal: BMC women's health
Published: December 02, 2024
Clinical characteristics and prognostic factors analysis of patients stricken with double primary breast and ovarian cancer based on the SEER database.
Journal: Gland surgery
Published: November 04, 2024
Semaglutide alleviates gut microbiota dysbiosis induced by a high-fat diet.
Journal: European journal of pharmacology
Published: October 07, 2023
Guiding the postoperative radioactive iodine-131 therapy for patients with papillary thyroid carcinoma according to the prognostic risk groups: a SEER-based study.
Journal: Journal of cancer research and clinical oncology
Published: April 19, 2023
Safety and immunogenicity of the third (booster) dose of inactivated and recombinant protein SARS-CoV-2 vaccine for patients with endocrine-related cancer.
Journal: Frontiers in public health
Published: December 08, 2022
Weakened humoral immune responses of inactivated SARS-CoV-2 vaccines in patients with solid tumors.
Journal: Cancer communications (London, England)
Published: March 27, 2022
[Corrigendum] miR‑382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumor‑associated macrophages by targeting PGC‑1α.
Journal: International journal of oncology
Published: March 22, 2022
miR‑382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumor‑associated macrophages by targeting PGC‑1α.
Journal: International journal of oncology
Published: March 22, 2022
Clinical Features and Prognosis Analysis of Hormone Receptor-Positive, HER2-Negative Breast Cancer with Differential Expression Levels of Estrogen and Progesterone Receptors: A 10-Year Retrospective Study.
Journal: The breast journal
Published: March 18, 2022
Last Updated: 09/26/2026